摘要
目的 探讨胸痛中心建设对急性心肌梗死患者救治效率及预后的影响.方法 选取2018年12月至2019年11月于安徽省六安市人民医院胸痛中心建设前的57例急性心肌梗死患者为对照组,另选取2019年12月至2020年11月胸痛中心建设后的54例急性心肌梗死患者为观察组,对比两组患者的救治效率及预后.结果 观察组症状发作-首次医疗接触时间(S-to-FMC)、首次医疗接触-球囊扩张时间(FMC-to-B)、门-球时间(D-to-B)、总缺血时间(Tit)、首次医疗接触-首份心电图时间(FMC-to-EKG)及住院时间均明显短于对照组,且FMC-to-B、D-to-B、FMC-to-EKG达标率分别为94.44％、94.44％、98.15％明显高于对照组73.68％、75.44％、77.19％(P＜0.05);术后第1d、3 d及7 d观察组肌钙蛋白Ⅰ(cTnⅠ)浓度明显低于对照组(P＜0.05);随访6个月,与对照组不良心血管事件发生率相比观察组明显较低(15.7％vs.3.70％)(P＜0.05).结论 胸痛中心建设能够提高急性心肌梗死患者的救治效率,降低不良心血管事件风险.
Abstract
Objective To discuss the influence of chest pain center construction on therapeutic efficacy and prognosis in patients with acute myocardial infarction(AMI).Methods AMI patients(n=57)were chosen into control group before chest pain center construction from People's Hospital of Lu`an City of Anhui Province from Dec.2018 to Nov.2019,and AMI patients(n=54)were chosen into observation group after chest pain center construction from Dec.2019 to Nov.2020.The therapeutic efficacy and prognosis were compared between 2 groups.Results The time of symptom onset-to-first medical contact time(S-to-FMC),FMC to balloon dilatation(FMC-to-B),door to balloon dilatation(D-to-B),total ischemia time(Tit),FMC to first electrocardiogram(FMC-to-EKG)and hospital stay were significantly shorter in observation group than those in control group.The compliance rates of FMC-to-B,D-to-B and FMC-to-EKG(94.44％,94.44％,98.15％)were significantly higher in observation group(94.44％,94.44％,98.15％)than those in control group(73.68％,75.44％,77.19％,P＜0.05).The concentration ofcardiac troponin Ⅰ(cTnⅠ)was significantly lower in observation group than that in control group on the 1st d,3nd d and 1 week after the operation(P＜0.05).After followed up for 6 months,the incidence of adverse cardiovascular events was significantly lower in observation group(3.70％)than that in control group(15.79％,P＜0.05).Conclusion The construction of chest pain center can improve the therapeutic efficacy and reduce the risk of adverse cardiovascular events in AMI patients.
维普
万方数据